112 related articles for article (PubMed ID: 37688413)
21. Protective and enhancing interactions among dengue viruses 1-4 and Zika virus.
Katzelnick LC; Bos S; Harris E
Curr Opin Virol; 2020 Aug; 43():59-70. PubMed ID: 32979816
[TBL] [Abstract][Full Text] [Related]
22. A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection.
Bonheur AN; Thomas S; Soshnick SH; McGibbon E; Dupuis AP; Hull R; Slavinski S; Del Rosso PE; Weiss D; Hunt DT; McCabe ME; Dean AB; Folkerth R; Laib AM; Wong SJ
BMC Infect Dis; 2021 Aug; 21(1):749. PubMed ID: 34348665
[TBL] [Abstract][Full Text] [Related]
23. Nucleoside Analogs with Selective Antiviral Activity against Dengue Fever and Japanese Encephalitis Viruses.
Zandi K; Bassit L; Amblard F; Cox BD; Hassandarvish P; Moghaddam E; Yueh A; Libanio Rodrigues GO; Passos I; Costa VV; AbuBakar S; Zhou L; Kohler J; Teixeira MM; Schinazi RF
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061163
[TBL] [Abstract][Full Text] [Related]
24. The Polyphenol-Rich Extract from
Clain E; Haddad JG; Koishi AC; Sinigaglia L; Rachidi W; Desprès P; Duarte Dos Santos CN; Guiraud P; Jouvenet N; El Kalamouni C
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991717
[TBL] [Abstract][Full Text] [Related]
25. Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long term.
Katzelnick LC; Zambrana JV; Elizondo D; Collado D; Garcia N; Arguello S; Mercado JC; Miranda T; Ampie O; Mercado BL; Narvaez C; Gresh L; Binder RA; Ojeda S; Sanchez N; Plazaola M; Latta K; Schiller A; Coloma J; Carrillo FB; Narvaez F; Halloran ME; Gordon A; Kuan G; Balmaseda A; Harris E
Sci Transl Med; 2021 Oct; 13(614):eabg9478. PubMed ID: 34613812
[TBL] [Abstract][Full Text] [Related]
26. Zika Virus Disease Comparing Children and Adults in a Dengue-Endemic Setting.
Wongsawat J; Vivong N; Suttha P; Utayamakul S; Aumpornareekul S; Chewcharat A; Chokephaibulkit K
Am J Trop Med Hyg; 2020 Nov; 104(2):557-563. PubMed ID: 33241785
[TBL] [Abstract][Full Text] [Related]
27. Dengue and Zika Virus 5' Untranslated Regions Harbor Internal Ribosomal Entry Site Functions.
Song Y; Mugavero J; Stauft CB; Wimmer E
mBio; 2019 Apr; 10(2):. PubMed ID: 30967466
[TBL] [Abstract][Full Text] [Related]
28. Harnessing Dengue Rapid Diagnostic Tests for the Combined Surveillance of Dengue, Zika, and Chikungunya Viruses in Laos.
Vongsouvath M; Bharucha T; Seephonelee M; de Lamballerie X; Newton PN; Dubot-Pérès A
Am J Trop Med Hyg; 2020 Jun; 102(6):1244-1248. PubMed ID: 32157991
[TBL] [Abstract][Full Text] [Related]
29. Development of multiplex real-time reverse-transcriptase polymerase chain reaction assay for simultaneous detection of Zika, dengue, yellow fever, and chikungunya viruses in a single tube.
Wu W; Wang J; Yu N; Yan J; Zhuo Z; Chen M; Su X; Fang M; He S; Zhang S; Zhang Y; Ge S; Xia N
J Med Virol; 2018 Nov; 90(11):1681-1686. PubMed ID: 29979812
[TBL] [Abstract][Full Text] [Related]
30. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
[TBL] [Abstract][Full Text] [Related]
31. Improved reverse transcription-polymerase chain reaction assay for the detection of flaviviruses with semi-nested primers for discrimination between dengue virus serotypes and Zika virus.
Nunes AR; Alves BEB; Pereira HW; Nascimento YM; Morais IC; Fernandes JV; Araújo JM; Lanza DC
Mem Inst Oswaldo Cruz; 2018; 113(5):e170393. PubMed ID: 29513820
[TBL] [Abstract][Full Text] [Related]
32. Cross-Reaction, Enhancement, and Neutralization Activity of Dengue Virus Antibodies against Zika Virus: A Study in the Mexican Population.
Montecillo-Aguado MR; Montes-Gómez AE; García-Cordero J; Corzo-Gómez J; Vivanco-Cid H; Mellado-Sánchez G; Muñoz-Medina JE; Gutiérrez-Castañeda B; Santos-Argumedo L; González-Bonilla C; Cedillo-Barrón L
J Immunol Res; 2019; 2019():7239347. PubMed ID: 31565661
[TBL] [Abstract][Full Text] [Related]
33. Unidentified dengue serotypes in DENV positive samples and detection of other pathogens responsible for an acute febrile illness outbreak 2016 in Cajamarca, Peru.
Del Valle-Mendoza J; Vasquez-Achaya F; Aguilar-Luis MA; Martins-Luna J; Bazán-Mayra J; Zavaleta-Gavidia V; Silva-Caso W; Carrillo-Ng H; Tarazona-Castro Y; Aquino-Ortega R; Del Valle LJ
BMC Res Notes; 2020 Oct; 13(1):467. PubMed ID: 33023645
[TBL] [Abstract][Full Text] [Related]
34. Sustained Specific and Cross-Reactive T Cell Responses to Zika and Dengue Virus NS3 in West Africa.
Herrera BB; Tsai WY; Chang CA; Hamel DJ; Wang WK; Lu Y; Mboup S; Kanki PJ
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321308
[TBL] [Abstract][Full Text] [Related]
35. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
Front Immunol; 2018; 9():597. PubMed ID: 29740424
[TBL] [Abstract][Full Text] [Related]
36. Genomic Sequencing of Dengue Virus Strains Associated with Papua New Guinean Outbreaks in 2016 Reveals Endemic Circulation of DENV-1 and DENV-2.
Jonduo M; Neave MJ; Javati S; Abala D; Bilo E; Kini A; Kumbu J; Laman M; Robinson LJ; Makita L; Susapu M; Pomat W; Abdad MY; Williams DT; Horwood PF
Am J Trop Med Hyg; 2022 Dec; 107(6):1234-1238. PubMed ID: 35895415
[TBL] [Abstract][Full Text] [Related]
37. Does prior dengue virus exposure worsen clinical outcomes of Zika virus infection? A systematic review, pooled analysis and lessons learned.
Masel J; McCracken MK; Gleeson T; Morrison B; Rutherford G; Imrie A; Jarman RG; Koren M; Pollett S
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007060. PubMed ID: 30682026
[TBL] [Abstract][Full Text] [Related]
38. Dengue, chikungunya and zika virus coinfection: results of the national surveillance during the zika epidemic in Colombia.
Mercado-Reyes M; Acosta-Reyes J; Navarro-Lechuga E; Corchuelo S; Rico A; Parra E; Tolosa N; Pardo L; González M; Martìn-Rodriguez-Hernández J; Karime-Osorio L; Ospina-Martinez M; Rodriguez-Perea H; Del Rio-Pertuz G; Viasus D
Epidemiol Infect; 2019 Jan; 147():e77. PubMed ID: 30869010
[TBL] [Abstract][Full Text] [Related]
39. Sulfated β-glucan from Agaricus subrufescens inhibits flavivirus infection and nonstructural protein 1-mediated pathogenesis.
Sousa FTG; Biering SB; Patel TS; Blanc SF; Camelini CM; Venzke D; Nunes RJ; Romano CM; Beatty PR; Sabino EC; Harris E
Antiviral Res; 2022 Jul; 203():105330. PubMed ID: 35533778
[TBL] [Abstract][Full Text] [Related]
40. Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development.
Elong Ngono A; Shresta S
Front Immunol; 2019; 10():1316. PubMed ID: 31244855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
